Aqueous colloidal nanoplatelets for imaging and improved ALA-based photodynamic therapy of prostate cancer cells

Kubra Onbasli, Gozde Demirci, Furkan Isik, Emek Goksu Durmusoglu, Hilmi Volkan Demir*, Havva Yagci Acar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Fluorescent, CdSe/CdS core/crown heterostructured nanoplatelets (NPLs) were transferred to the water via a simple, single-step ligand exchange using 2-mercaptopropionic acid in a simple extraction process. These stable, aqueous NPLs were loaded with a modal drug, 5-aminolevulinic acid (ALA). ALA-loaded NPLs emerged as a new class of theranostic nanoparticles for image-guided enhanced photodynamic therapy of both androgen-dependent and -independent human prostate cancer cells.

Original languageEnglish
Pages (from-to)10512-10515
Number of pages4
JournalChemical Communications
Volume59
Issue number70
DOIs
Publication statusPublished - 21 Jul 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 The Royal Society of Chemistry.

Fingerprint

Dive into the research topics of 'Aqueous colloidal nanoplatelets for imaging and improved ALA-based photodynamic therapy of prostate cancer cells'. Together they form a unique fingerprint.

Cite this